March 1 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* CYNATA ADVANCES PLANNED CLINICAL TRIAL IN DIABETIC FOOT ULCERS IN MOU WITH TEKCYTE
* CYNATA THERAPEUTICS LTD - PLANS TO UNDERTAKE CLINICAL TRIAL OF ITS CYMERUS MSC PRODUCT BASED ON PRE-CLINICAL FOUNDATION, UTILISING TEKCYTE TECHNOLOGY
* CYNATA THERAPEUTICS LTD - TEKCYTE WILL WORK WITH CYNATA TO MANUFACTURE AND SUPPLY ACTIVE DRESSING FOR PLANNED CLINICAL TRIAL